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Abstract  1 
Enterotoxigenic Escherichia coli (ETEC) expressing the colonization factor CS6 is widespread 2 
in many developing countries including India. The different allelic variants of CS6, caused by 3 
point mutations in its structural genes cssA and cssB, are designated as AIBI, AIIBII, AIIIBI, 4 
AIBII, and AIIIBII. A simple, reliable and specific mismatch amplification mutation assay based 5 
on real-time polymerase chain reaction (MAMA-qPCR) was developed for the first time for 6 
detection of CS6-expressing ETEC along with specification of allelic variations. This assay was 7 
based on mismatch nucleotide incorporation at the penultimate base at the 3′-end of the reverse 8 
primers specific for cssA and cssB and was validated using 38 CS6-expressing ETEC isolates. 9 
This strategy was effective in detecting all the alleles containing single nucleotide 10 
polymorphism.  Using MAMA-qPCR we have also tested CS6 allelic variants in 145 ETEC 11 
isolated from children with acute diarrhea and asymptomatic infections, the latter serving as 12 
controls. We observed that AIBI and AIIIBI allelic variants were mostly associated with cases 13 
rather than controls, whereas the AIIBII variants were detected mostly in controls. In addition, 14 
the AIBI and AIIIBI alleles were frequently associated with ETEC harboring est alone or with elt 15 
genes, whereas AIIBII allele was predominant in ETEC isolates harboring elt gene.  This study 16 
may help in understanding the association of allelic variants in CS6-expressing ETEC with the 17 
clinical features of diarrhea as well as in ETEC vaccine studies.  18 
 19 
 20 
 21 
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Introduction 1 
Enterotoxigenic Escherichia coli (ETEC), Vibrio cholerae O1and rotavirus, account for a 2 
majority of the most severe form of acute diarrhea that can turn fatal in the absence of timely 3 
intervention. The virulence factors of ETEC are one or both of the two enterotoxins (6, 14), 4 
commonly known as heat-labile (LT) and heat-stable (ST) depending on their temperature 5 
susceptibility, and a group of cell surface proteins, collectively called colonization factor 6 
antigens (CFAs). The CFAs enable the organisms to adhere to host intestinal cells effectively to 7 
initiate pathogenesis (15, 18) by overcoming intestinal peristalsis and mucous barrier. Several 8 
studies indicate that 20-40% of the travelers from developed countries experience ETEC-9 
mediated diarrhea in developing countries that are endemic for diarrheal pathogens (4). 10 
According to the World Health Organization (WHO), ETEC is the second most common cause 11 
of diarrhea after rotavirus in children less than 5 years of age and this age group is the main 12 
target for vaccine implementation (8). 13 
In the majority of developing countries, CS6 is one of the major CFAs among ETEC. Till date, 14 
more than 20 CFAs are known, of which CS6 is the most prevalent globally (6, 5, 19). Recent 15 
studies indicate that infection caused by CS6-expressing ETEC alone account for up to 20% of 16 
the total diarrheal cases in south-east Asia (1). Due to the increase in the incidence of ETEC-17 
mediated diarrheal disease, considerable attention has been paid to the development of simple, 18 
sensitive molecular methods for rapid identification of this pathogen. Currently, CFA’s are 19 
detected by normal PCR assay, substituting the conventional immunological tests (7, 12, 13, 16, 20 
17). 21 
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The CS6 operon is composed of four genes, namely cssA, cssB, cssC and cssD. The cssA and 1 
cssB genes are the structural genes of CS6 that exhibit variation in different CS6-expressing 2 
ETEC isolates (16, 20). Recently, we have documented that cssA gene of CS6 has three alleles 3 
(AI, AII, and AIII), and cssB gene has two alleles (BI, BII) that show differential binding with 4 
human intestinal epithelial cells (Caco-2) (16). Following identification of CS6-expressing 5 
ETEC by PCR or antibody based detection methods, molecular techniques such as allele-specific 6 
PCR and DNA sequencing are helpful in the detection of CS6 variants. However, these methods 7 
are laborious and time-consuming for diagnostic purposes. Till date, there is no simple, specific 8 
and rapid detection method for ETEC expressing CS6 alleles.   9 
In this study, we have developed a rapid qPCR-based mismatch amplification mutation assay 10 
(MAMA) (2) for the detection of CS6 allelic variants that can be completed within 2 hrs after the 11 
DNA extraction from the ETEC isolates. Using this new assay, we screened 145 ETEC isolates 12 
for the detection of different alleles of both cssA and cssB genes of CS6 and their association 13 
with diarrheal and asymptomatic infections.  14 
 15 
Materials and Methods 16 
Bacterial strains and culture conditions: Stool specimens were collected from the acute 17 
diarrheal children below five years of age from the Infectious Diseases Hospital and B. C. Roy 18 
Memorial Hospital for children, Kolkata, India. Stool specimens were also collected from age 19 
and sex matched asymptomatic controls from the community. All the stool specimens were 20 
examined for common enteric pathogens using standardized methods (10). Three lactose 21 
fermenting pink colonies resembling Escherichia coli from MacConkey agar plates were sub-22 
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cultured on normal Luria-Bertani agar (Difco, Sparks, MD) plate and screened for the 1 
diarrheagenic E. coli (DEC) as described previously (11, 15). After confirmation, all the ETEC 2 
isolates were serotyped using commercially available O and H antisera (Denka Seiken, Tokyo, 3 
Japan). All the ETEC isolates were stored at -80°C in Luria-Bertani broth (Difco) with 15% 4 
glycerol until further use. A well characterized ETEC CS6 strain 4266 (7) and a K12 E. coli 5 
strain DH5 were used as PCR positive and negative control strains, respectively.  6 
Genomic DNA isolation: ETEC isolates were sub-cultured from -80°C stock on CFA medium 7 
(1% Casamino acid, 0.15% yeast extract, 0.005% MgSO4, 0.005% MnCl2, pH 7.4). After 24 hrs 8 
incubation at 37°C, total genomic DNA was isolated by NucliSENS EasyMag (biomérieux, 9 
Marcy l’Etoile, France) machine according to manufacturer’s protocol. One ETEC isolate per 10 
patient was used in this study and presence of CS6 was confirmed by PCR as described before 11 
(16). 12 
Primer design for mismatch qPCR:  The MAMA primer to detect the sequence polymorphism 13 
among cssAI, cssAII, cssAIII, cssBI and cssBII subunit genes was focused on nucleotide position 14 
169 and 474 for cssA and cssB subunit genes of CS6, respectively (Fig.1 A, B). Two conserved 15 
forward primers for cssA  and cssB genes and five allele-specific polymorphism detection 16 
primers, RV-cssAI, RVcssAII, RV-cssAIII, RV-cssBI  and RV-cssBII  were designed (Table 1).   17 
At 3′ end, these allele-specific primers contained G, C and A for cssAI, cssAII and cssAIII and C 18 
and A for cssBI, cssBII, respectively. To increase the specificity of the 3′mismatch activity, 19 
nucleotide C was incorporated (rather than T and/or A) at the penultimate nucleotide of 5′- 3′ 20 
reverse primers of all CS6 subunit alleles. A conserved forward primer (FO-parC) and a reverse 21 
primer (RV-parC) of the housekeeping gene parC were used as an internal control.  22 
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qPCR reaction condition: qPCR for the detection of mutations was done in a 20µl reaction 1 
volume containing 2µl of total genomic DNA (~60ng of DNA in a sterile Tris-EDTA), 1X PCR 2 
SYBR Green Master Mix (Applied Biosystems, Foster City, CA), 0.2µM forward and MAMA 3 
reverse primers and Milli-Q water to make up the final volume.  Thirty cycles of qPCR were 4 
carried out as follows:  stage 1, 95°C for 15 min (enzyme activation) followed by stage 2,  30 5 
cycles of 95°C for 20s, 49°C for 35s, and 60°C, 45 s and stage 3, for dissociation (of each primer 6 
from template) on an Applied Biosystem 7500 thermal cycler. Data for analysis were collected at 7 
the last step of stage 2. Melting curve was also analyzed at the dissociation step of stage 3 in 8 
each experiment to understand the primer dissociation from the template. 9 
 Conventional PCR: ETEC toxin genes that encode LT and ST were detected by multiplex PCR 10 
as described before (11). To check the non-specific amplicons if any, a conventional PCR using 11 
the same MAMA primers for all the CS6 alleles were made. PCR was performed in a 20µl 12 
volume consisting of 2X PCR Master Mix (QIAGEN Fast Cycling PCR Kit, Qiagen, CA), 13 
0.2µM forward and MAMA reverse primers. PCR conditions are as follows: 95°C, 5mins for 14 
initial activation of HotStar Taq plus DNA polymerase, 28 cycles of 96°C for 5s; 51°C for 5s 15 
and 68°C for 10s, and a final extension step of 1 min at 72°C on an Eppendorf thermal cycler. 16 
The amplified products were visualized on a 3% agarose gel after ethidium bromide staining 17 
using Geldoc system (BioRad, Hercules, CA). 18 
Statistical Analysis: CS6 allelic variants in cases and controls were tested by univariate analysis 19 
and 2 exact tests. Probability level (P) value of ≤0.05 was considered statistically significant.  20 
 21 
 22 
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Results 1 
Specificity of MAMA-qPCR primer pairs 2 
To determine the specificity of MAMA-qPCR, we used the DNA of 38 previously characterized 3 
CS6 positive ETEC isolates. CS6 negative ETEC isolates and non-ETEC such as Vibrio 4 
cholerae, enteropathogenic E. coli, enteroaggregative E. coli and Campylobactor spp. were 5 
included in the assay. As expected, the assay was negative for CS6 negative ETEC and non-6 
ETEC isolates but was positive for only previously characterized CS6 positive ETEC isolates. 7 
Allelic variations were detected in all the CS6 positive ETEC isolates. The internal test control 8 
parC gave positive Ct values in case of enteropathogenic E. coli, enteroaggrogetive E. coli, and 9 
all the ETEC isolates (data not shown). A representative gel picture for CS6 allelic variants is 10 
shown in Fig. 2. Our results indicate that all the tested MAMA primers were CS6 allele specific 11 
and did not cross react with other bacterial genes tested in this study.  12 
MAMA-qPCR based identification of CS6 allelic variants by among ETEC isolates from 13 
case and controls  14 
Thirty eight previously characterized CS6 positive ETEC isolates were selected to validate the 15 
MAMA-qPCR assay. In all these isolates, CS6 alleles were confirmed by DNA sequencing (16). 16 
Using MAMA-qPCR, we screened additional 105 ETEC isolates from diarrheal cases and 40 17 
from controls. Overall, 49% of the ETEC isolates expressed CS6. In the MAMA-qPCR, AIBI 18 
(n=40), AIIIBI (n=18), AIIBII (n=6), AIBII (n=3) and AIIIBII (n=4) were detected in ETEC 19 
isolates (Table 2). Most of the ETEC isolates from diarrheal cases harbored AIBI allele (34%) in 20 
comparison to the controls (10%). AIBI variant was 9 times significantly higher [OR=3.68 (95% 21 
CI=0.88-16.41); P=0.039] in cases than in controls. Though it is not significant [OR=2.10 (95% 22 
CI=0.37-15.40); P=0.298], the AIIIBI variant was 8 times higher in cases than controls. 23 
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Conversely, the occurrence of AIIBII variant was comparatively more in controls (10%) than 1 
cases (2%), which was highly significant (P<0.001). In this study, AIBII and AIIIBII variants 2 
were detected in very low numbers and the AIIBI variant was not found among ETEC isolates.        3 
Correlation between CS6 allelic variants and toxin genes 4 
We have tested the toxin types of ETEC isolates by a multiplex PCR method (11) targeting the 5 
elt and est genes and correlated their occurrence with the specific CS6 allele (Table 3). It was 6 
found that 28 (48%) of the CS6-expressing ETEC isolated from diarrheal cases harbored elt and 7 
est genes, of which 22 (76%) were AIBI allelic variant, 5 (17.2%) were AIIIBI and one isolate 8 
belonged to AIIBII variant. Out of 13 ETEC isolates from controls, 3 harbored CS6 as well as elt 9 
and est genes. Among 16 est positive ETEC isolates from diarrheal cases 6 had AIBI allele, 7 10 
with AIIIBI, 2 with AIIIBII and one had AIIIBII. From controls, only 4 ETEC isolates were 11 
positive for est gene. The elt gene was detected in 13 ETEC isolates from cases, in which 8 12 
belonged to AIBI allele, 4 isolates to AIIIBI and one to AIBII. Interestingly, most of the AIIBII 13 
variant was found to be associated with ETEC isolates from controls that harbored only the elt. 14 
The most commonly detected toxin encoding genes among CS6 allelic variants in order of 15 
frequency were   elt+est >est >elt. Most of the AIBI allelic variant among cases harbored both 16 
est and elt. The CS6 negative ETEC mostly harbored est (data not shown). The serotyping results 17 
showed that majority of the ETEC isolates belongs to different serotypes (data not shown). 18 
Discussion 19 
Allelic variation in CS6 expressing ETEC is a recent observation that has several implications in 20 
the epidemiology of ETEC-mediated diarrhea (16). The screening of these CS6 allelic variants is 21 
critical for understanding the correlation of micro-evolutionary changes of this pathogen with 22 
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clinical severity of the disease and its implication for ETEC vaccine development. Currently, 1 
DNA sequencing is the definitive method for identification of CS6 allelic variants. Since 2 
sequencing is not practical in studies involving large number of samples and hence it is 3 
appropriate to develop a method that is rapid, reliable and cost-effective in clinical and 4 
community settings.   Considering the existing number of CS6 allelic variants, real-time PCR can 5 
effectively be used as an alternative to the DNA sequencing. MAMA-PCR has become the most 6 
important tool in identifying single nucleotide variation with epidemiological significance. 7 
Previously, this technique was used for the differentiation of cholera toxin B subunit in newly 8 
emerged El Tor hybrid strains of V. cholerae O1 that has spread in several endemic regions (9). 9 
In this study, we have developed a simple, specific, reliable and cost-effective MAMA-qPCR 10 
assay for the differentiation of CS6 expressing ETEC variants that can detect nanogram level of 11 
DNA and costs about 10 USD per sample, which is much less than DNA sequencing costs. 12 
Further to simplify the assay DNA extraction from ETEC isolates by simple heating method may 13 
also be adopted. 14 
In addition to the formulation of this MAMA-qPCR, we applied the assay to ETEC isolates from 15 
children below five years of age with acute diarrhea and age and sex matched controls from the 16 
urban community. Many studies with ETEC have shown that CS6 was the most prevalent CF 17 
type in developing countries (3, 7, 12, 16). Overall, the AIBI variant was the most prevalent 18 
among CS6-expressing ETEC isolates in Kolkata. This inference should be further confirmed 19 
with more number of ETEC from diarrheal cases and normal controls. It was also observed that 20 
AIBI was the most frequently detected CS6 variant in ETEC isolates from cases, whereas the 21 
AIIBII variant was mainly found in the control group. Simultaneous occurrence of LT and ST 22 
toxin types in ETEC was significantly higher among AIBI variant whereas AIIBII variant of 23 
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ETEC were associated with LT alone.  Previous epidemiological studies with ETEC have shown 1 
that LT toxin-producing ETEC were significantly associated in controls than ST/ST+LT toxin 2 
type (12).  In our previous study, we have shown that in the presence of BII allele, the CS6 3 
expressing ETEC binds to Caco-2 cells with less affinity than the BI allele expressing ETEC 4 
(16). Based on our findings, it is possible that the LT-ETEC is associated with less severe 5 
clinical cases due to less adherence ability of this allelic type. Further molecular and 6 
epidemiological studies are required to prove this presumption. 7 
In summary, the MAMA-qPCR method is a reliable, cost-effective and simple method for the 8 
detection of CS6 expressing ETEC isolates and its allelic variants. This assay also provides 9 
information relevant to severity of ETEC-induced diarrhea and development of vaccines against 10 
CS6-expressing ETEC.  11 
 12 
Acknowledgement 13 
This study was supported in part by grants from Program of Founding Research Center for 14 
Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science 15 
and Technology of Japan, Global Enteric Multicentre Study, University of Maryland, Baltimore, 16 
USA and Grant-in-aid from Indian Council of Medical Research (ICMR), India.   17 
 18 
 19 
 20 
 21 
11 
 
References 1 
1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, 2 
Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C. 2010. Global, 3 
regional, and national causes of child mortality in 2008: a systematic analysis. Lancet, 4 
37:1969-1987.  5 
2. Cha R.S., Zarbl H., Keohavong P., ThillyW.G. 1992. Mismatch amplification mutation 6 
assay (MAMA): application to the c-H-ras gene. PCR Methods Appl 2:14–20.  7 
3. Cohen D, Tobias J, Spungin-Bialik A, Sela T, Kayouf R, Volovik Y, Yavzori M, 8 
Ephros M. 2010. Phenotypic characteristics of enterotoxigenic Escherichia coli 9 
associated with acute diarrhea among Israeli young adults. Foodborne Pathog Dis. 10 
7:1159-1164. 11 
4. DuPont, H. L., S. B. Formal, R. B. Hornick, M. J. Snyder, J. P. Libonati, D. G. 12 
Sheahan, E. H. LaBrec, and J. P. Kalas. 1971. Pathogenesis of Escherichia coli 13 
diarrhea. N. Engl. J. Med. 285:1–9. 14 
5. Firdausi Qadri, Svennerholm, A. M., Faruque, A. S. G., and Sack, R. B. 2005. 15 
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, 16 
Clinical Features,Treatment, and Prevention. J Clin Microbiol Rev. 18:465-483. 17 
6. Gaastra, W. & Svennerholm, A. M. 1996. Colonization factors of human 18 
enterotoxigenic Escherichia coli (ETEC). Trends  Microbiol  4:444-452. 19 
7. Ghosal, A., Bhowmick, R., Nandy, R. K., Ramamurthy, T. & Chatterjee, N. S. 2007. 20 
PCR-Based identiﬁcation of common colonization factor antigens of enterotoxigenic 21 
Escherichia coli. J Clin Microbiol 45:3068-3071. 22 
12 
 
8. Lanata, C. F., W. Mendoza, and R. E. Black. 2002. Improving diarrhoea estimates. 1 
WHO, Geneva, Switzerland. 2 
9. Masatomo Morita, Makoto Ohnishi, Eiji Arakawa, Bhuiyan, N.A., Suraia Nusrin, 3 
Munirul Alam, Siddique, A.K., Firdausi Qadri, Hidemasa Izumiya, G. Balakrish 4 
Nair and Haruo Watanabe. 2008. Development and validation of a mismatch 5 
amplification mutation PCR assay to monitor the dissemination of an emerging variant of 6 
Vibrio cholerae O1 biotype El Tor. Microbiol Immunol.52:314-317.  7 
10. Nair, G. B., Ramamurthy, T., Bhattacharya, M. K., Krishnan, T., Ganguly, S., Saha, 8 
D. R., Rajendran, K., Manna, B., Ghosh, M., Okamoto, K., Takeda, Y. 2010. 9 
Emerging trends in the etiology of enteric pathogens as evidenced from an active 10 
surveillance of hospitalized diarrhoeal patients in Kolkata, India. Gut Pathog. 2(1):4. 11 
11. Nguyen, T. V., Le Van, P., Le Huy, C., Gia, K.N. & Weintraub, A. 2005. Detection 12 
and characterization of diarrheagenic Escherichia coli from young children in Hanoi, 13 
Vietnam. J Clin Microbial. 43, 755-760. 14 
12. Rivera FP, Ochoa TJ, Maves RC, Bernal M, Medina AM, Meza R, Barletta F, 15 
Mercado E, Ecker L, Gil AI, Hall ER, Huicho L, Lanata CF. 2010. Genotypic and 16 
phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from 17 
Peruvian children. J Clin Microbiol. 48:3198-203.   18 
13. Rodas, C., Iniguez, V., Qadri, F., Wiklund, G., Svennerholm, A. M. & Sjoling, A. 19 
2009. Development of multiplex PCR assays for detection of enterotoxigenic Escherichia 20 
coli colonization factor and toxins. J Clin Microbiol 47:1218-1220. 21 
13 
 
14. Sack, R. B. 1975. Human diarrheal disease caused by enterotoxigenic Escherichia coli. 1 
Annual rev of Microbiol 29:333-353.  2 
15. Sack, R.B. 1980. Enterotoxigenic Escherichia coli: Identification and characterization. J. 3 
Infect Dis, 142: 279-86. 4 
16. Sabui S, Ghosal A, Dutta S, Ghosh A, Ramamurthy T, Nataro J. P., Hamabata T, 5 
Chatterjee N. S. 2010. Allelic variation in colonization factor CS6 of enterotoxigenic 6 
Escherichia coli isolated from patients with acute diarrhoea and controls. J Med 7 
Microbiol. 59:770-779. 8 
17. Vidal, M. R., Valenzuela, P., Baker, K., Lagos, R., Esparza, M., Livio, S., Farfan, 9 
M., Nataro, J. P., Levine, M. M. & Prado, V. 2009. Characterization of the most 10 
prevalent colonization factor antigens present in Chilean clinical enterotoxigenic 11 
Escherichia coli strains using a new multiplex polymerase chain reaction. Diagn 12 
Microbiol And Infect Dis 65:217-223.  13 
18. Wolf, M. K. 1997. Occurrence, distribution, and associations of O and H serogroups, 14 
colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. J Clin 15 
Microbiol Rev 10:569-584. 16 
19. Wolf, M. K., Andrews, G.P., Tall, B. D., McConnell, M. M., Levine, M. M. & 17 
Boedeker, E. C. 1989. Characterization of CS4 and CS6 antigen components of 18 
PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli 19 
E8775. Infect Immun  57:164-173.  20 
20. Wolf, M. K., Hann, de L. A. M., Cassels, F. J., Willshaw, G. A., Warren, R., 21 
Boedeker, E. C. & Gasstra, W. 1997. The CS6 colonization factor of human 22 
14 
 
enterotoxigenic Escherichia coli contains two heterologous major subunits. FEMS 1 
Mocrobiol Lett 148:35-42.  2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
15 
 
Figure legends 1 
Fig. 1: Sequence alignment of cssA and cssB subunit genes of CS6 expressing ETEC. Three 2 
allele of cssA and two allele of cssB subunit were aligned by using clustalW2 software 3 
(http://www.ebi.ac.uk/Tools/msa/clustalw2), respectively. Star (*) marks are indicated the 4 
conserved nucleotides and gap regions are indicated single nucleotide polymorphisms (SNPs) at 5 
different position of cssA and cssB alleles. The primer regions are indicated by bold and mutated 6 
nucleotides of the reverse primer are shown in box.  Identical regions between CS6 alleles are 7 
indicated in dotted line and the position of the nucleotide shown at right side.  8 
 9 
Fig. 6: Agarose gel of MAMA PCR product for CS6 allelic variants. A; Lane 1, 2, 3, 4, and 5 10 
indicates AI, AII, AIII, BI and BII allele from strain IDH00200, respectively. Lane 6, 7, 8, 9 and 11 
10 indicates AI, AII, AIII, BI and BII allele from strain SD173, respectively. Lane 11, 12, 13, 14 12 
and 15 indicates AI, AII, AIII, BI and BII allele from strain SD276, respectively. B, Lane 1, 2, 3 13 
indicates parC gene from strain IDH00200, SD173 and SD276, respectively.  14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
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Table 1. Oligonucleotide sequences of primers used in MAMA-qPCR assay 1 
 2 
Target 
gene 
Location Oligonucleotide Sequence Amplicon 
size (bp) 
cssAI 55      189a FO-cssA: 5′-AGAACAGAAATAGCGACTA-3′ 
RV-cssAI: 5′GCTCACACTAAATAATAACC-3′ 
135 
cssAII 55      189b FO-cssA: 5′-AGAACAGAAATAGCGACTA-3′ 
RV-cssAII:5′-GCTCACACTAAATAATAACG-3′ 
135 
cssAIII 55      189c FO-cssA: 5′-AGAACAGAAATAGCGACTA-3′ 
RV-cssAIII:5′-GCTCACACTAAATAATAACT-3′ 
135 
cssBI    328       494d FO-cssB: 5′-ATCAGAAAGGATTCTGGC-3′ 
RV-cssBI:5′-GTAAAATGATACACTCAAACG-3′ 
167 
cssBII 328       494e FO-cssB: 5′-ATCAGAAAGGATTCTGGC-3′ 
RV-cssBII:5′-GTAAAATGATACACTCAAACT-3′ 
167 
parC 63       162f FO-parC: 5′-TGGATCGTGCGTTGCCGTTTATTG-3′ 
RV-parC:5′- AATTTGGCGGTAGCATTCAGACCC-3′ 
100 
a, GeneBank Accession Number GQ241334  3 
b, GeneBank Accession Number GQ241330 4 
c, GeneBank Accession Number GQ241332 5 
d, GeneBank Accession Number GQ241335 6 
e, GeneBank Accession Number GQ241337 7 
f, GeneBank Accession Number EU561348 8 
 9 
 10 
 11 
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Table 2. ETEC-CS6 allelic variants detected by MAMA-qPCR from case and control  1 
CS6 allelic 
Variant 
Number of CS6 positive ETEC 
Case                   Control 
(n=58)                  (n=13) 
OR (95% CI) P-value 
AIBI 
 
AIIIBI 
 
AIIBII 
 
AIBII 
 
AIIIBII 
36 4 
 
16                           2 
 
2                            4 
 
1                            2 
 
3                    1 
3.68 (0.88-16.41) 
 
2.10 (0.37-15.40) 
 
0.08 (0.01-0.63) 
 
0.10 (0.00-1.55) 
 
0.65 (0.05-17.84) 
0.039*cs 
 
0.298 
 
0.009*ct 
 
0.084 
 
0.563 
 2 
*cs =statistically significant association with cases 3 
*ct =statistically significant association with control  4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
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Table 3. Relationship between toxin genes and CS6 allelic variants of CS6 expressing ETEC  1 
CS6 allelic 
variants 
Case*(n=58) Control# (n=13) 
elt+est elt est elt+est elt est 
AIBI 22 8 6 2 2 - 
AIIIBI 5 4 7 1 - 1 
AIIBII 1 - 1 - 4 - 
AIBII - 1 - - - 2 
AIIIBII - - 2 - - 1 
Case*, CS6 expressing ETEC was isolated from diarrheal patients as a mixed or sole pathogen 2 
Control#, CS6 expressing ETEC was isolated from normal children as a mixed or sole pathogen 3 
n, total number of ETEC isolates 4 
-, indicates ETEC were not detected of that toxin type 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
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